Industry
Pharmaceuticals
Topic
Product Launch
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Product Launch in Pharmaceuticals
... OAKVILLE - Concordia International Corp. ('Concordia' or the 'Company') (NASDAQ: CXRX) (TSX: CXR), an international specialty ...
... Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of ...
... received in July 2016upon the execution of Jounce's global strategic collaboration with Celgene. Research and Development (R&D) Expenses: R&D expenses were $ 17.1 millionfor the ...
... TORONTO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) is pleased ...
... 2017Concluded the third quarter with a cash balance of $341.3 million Concordia International Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international specialty ...
... CANADIAN DAILY STOCK REPORT Medicure Inc. (TSXV:MPH), Canada's 11th largest Biotechnology company by market cap, traded at its ...
... HERTFORDSHIRE, England and PITTSBURGH - Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Clofarabine Injection, 20 mg/20 ...
... in July 2016 upon the execution of Jounce's global strategic collaboration with Celgene. Research and Development (R&D) Expenses: R&D expenses were $17.1 million for the ...
... was formerly Vice-President and Global Head of Quality, Compliance and Regulatory at Lonza, the world's largest biologics contract-manufacturing company. At Lonza, Sam developed and led ...
... Sage Therapeutics(NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central ...
... On November 09, 2017 (the "Effective Date"), Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company") entered into a Confidential Settlement ...
... Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in the building of ...
... CANADIAN DAILY STOCK REPORT Medicure Inc. (TSXV:MPH), Canada's 11th largest Biotechnology company by market cap, has lifted 29.0c ...
... BUENA, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has ...
... Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Clofarabine Injection, 20 mg/20 ...
... 373 crores for the same period last year, showing 13% growth. About Torrent Pharma Torrent Pharma, with annual revenues of more than Rs. 5800 crores ...
... a new trial and vacated permanent injunction in U.S. Praluent®patent case Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) today announced financial results for the third quarter of 2017 ...
... The report on global microbiome therapeutics market evaluates the growth trends of the industry through historical study ...
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care, gastroenterology, ...
... Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi today announced new data analyses from the Praluent® ...
... WINNIPEG - Medicure Inc. ('Medicure' or the 'Company') (TSXV: MPH, OTC: MCUJF), a specialty pharmaceutical company, ...
... CAMBRIDGE, Mass. - Sage Therapeutics, Inc. (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering ...
... Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building of businesses ...
... CANADIAN DAILY STOCK REPORT Medicure Inc. (TSXV:MPH), Canada's 11th largest Biotechnology company by market cap, extended its gains ...
... During the drugmaker's third-quarter earnings call with investors, Pfizer CEO Ian Read attributed growing sales of eczema drug Eucrisa to the ...
... TARRYTOWN, N.Y. - Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 1 clinical ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤